mRNA |
Crizotinib |
GDSC1000 |
pan-cancer |
AAC |
0.078 |
0.1 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
Vorinostat |
gCSI |
pan-cancer |
AAC |
-0.076 |
0.1 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
0.073 |
0.1 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.1 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.1 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.1 |
mRNA |
PD-0332991 |
CCLE |
pan-cancer |
AAC |
0.073 |
0.1 |
mRNA |
Gefitinib |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |